Samsung Electronics has slipped to fourth place in global semiconductor market capitalization rankings, surpassed by U.S.-based fabless semiconductor firm Broadcom. Non-memory companies such as Nvidia and Broadcom are expanding their territories through massive investments and mergers and acquisitio
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company’s CEO, Jaeyong Ahn has virtually participated as a panelist in the academic workshop session of ‘Pandemic Product Research and Development: Insights from P
GC Biopharma’s and SK plasma’s entries into Indonesia will accelerate this year. GC Biopharma is expected to finalize all procedures within this year after receiving approval for business rights related to the construction of a blood product factory and a technology transfer from the Indonesian gove
A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.Through joint research with the Korea Institute of Machinery and Materials (President Sang Jin Park, hereinafter referred to as KI
New investments in venture startups plunged by one third in the first half of the year. The number of startups that received big investments plummeted.According to startup investment information platform TheVC, startups and SMEs received 2.819 trillion won (US$2.160 billion) in investment in the fir
The author is an analyst for NH Investment & Securities. He can be reached at pk.park@nhqv.com -- Ed.Although SK Biopharm’s operating losses likely narrowed q-q in 2Q23, we believe that COGS-to-sales ratio returned to the previous high level, and SG&A expenses likely upped q-q on clinical costs. How
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has signed a Memorandum of Understanding (MOU) with the Government Pharmaceutical Organization (GPO), a state pharmaceutical enterprise in Thailand, to str
Nine merger and acquisition (M&A) deals worth more than US$1 billion were made in the global pharmaceutical and bio industries in the first half of this year.According to the Korea Biotechnology Industry Organization (KBIO) on July 2, the global pharmaceutical and bio industries recorded nine M&A de
On July 1 (local time), the U.S. Humira biosimilar market, worth 24 trillion won a year, opened. In the first week alone, six Korean and foreign companies plan to launch their products.According to sources in the biotech industry on July 2, Samsung Bioepis launched Hadlima, a Humira biosimilar, in t
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced positive results from its Phase II clinical trials in infants of its 21-valent pneumococcal conjugate vaccine candidate, ‘GBP410’ (also known as SP0202), evaluating i
SK pharmteco, SK Inc.’s contract development manufacturing organization (CDMO) for pharmaceuticals, successfully completed its second facility for Cell and Gene Therapies (C>) manufacturing in Europe. With this milestone, SK pharmteco is rapidly expanding its presence in the global market.SK pharm
Samsung Chairman Lee Jae-yong, SK Chairman Chey Tae-won, Hyundai Motor Chung Eui-sun, and LG Chairman Koo Kwang-mo discussed bilateral cooperation on energy, biotechnology and future transportation in a meeting with French President Emmanuel Macron.The Korean business leaders met with President Macr
The Korean government will announce a plan to ease special listing requirements for excellent companies with cutting-edge technologies in the semiconductor, bio, artificial intelligence, and secondary battery sectors in July.The Financial Services Commission (FSC) will map out the plan by forming a
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced the company has received the WHO Emergency Use Listing (EUL) of its COVID-19 vaccine, SKYCovione.SKYCovione is a self-assembled nanoparticle vaccine targeting the rec
Samsung BioLogics is moving closer to attaining its goal of becoming a top-tier global biotech company.John Lim, CEO of Samsung BioLogics, held a press conference at Bio USA in Boston, the United States on June 5 (local time) and revealed the status of his company’s contract manufacture organization
Celltrion announced on June 5 that it had signed a contract with Rani Therapeutics, a biotech company based in San Jose, California, to develop an oral version of adalimumab (development name: RT-105).Earlier this year in January, Celltrion had signed a new drug development contract for the oral ver
The author is an analyst for NH Investment & Securities. He can be reached at pk.park@nhqv.com -- Ed.Having endured a shrinking in their Kospi portion, the top-5 healthcare groups should enjoy a sharp top-line uptrend from 2024. Their combined annual sales are primed to reach W23.5tn in 2028 (5yr CA
GeneOne Life Science announced on June 1 that it has hired Jeff Whitmore as the Chief Commercial Officer (CCO) of its subsidiary VGXI, a contract development and manufacturing organization (CDMO) for plasmid DNA and RNA drugs.The newly appointed CCO Whitmore will oversee the operations of VGXI's
Pharmaceutical and biotech companies from Korea will be attending the “2023 Bio International Convention” held in Boston, Massachusetts, the U.S., from June 5 to 8. The convention is the largest biotech and pharmaceutical exhibition in the world and is organized by the Biotechnology Innovative Organ
On May 25, HanAll Biopharma and Daewoong Pharma announced a joint development agreement on potential treatments for degenerative neurological diseases. The agreement centers on ATH-399A, a leading candidate for Parkinson's disease treatment, currently under development at NurrOn Pharmaceuticals.